Sanara MedTech (SMTI) Change in Accured Expenses (2010 - 2024)

Sanara MedTech has reported Change in Accured Expenses for 14 years, with the latest figure at -$783390.0 in Q1 2024.

• For the quarter ending Q1 2024, Change in Accured Expenses rose 59.81% year-over-year to -$783390.0; the trailing twelve-month figure through Mar 2024 stood at $1.1 million (down 25.46% YoY), and the FY2023 full-year result was -$81513.0, down 102.72% from the prior year.
• Change in Accured Expenses for Q1 2024 stood at -$783390.0, down from $1.6 million in the prior quarter.
• The five-year high for Change in Accured Expenses was $1.6 million in Q4 2023, with the low at -$1.9 million in Q1 2023.
• Historically, Change in Accured Expenses has averaged $231970.4 across 5 years, with a median of $325788.0 in 2020.
• Annual changes were most pronounced in 2020 — Change in Accured Expenses plunged 380.24% — and 2022, when it surged 419.97%.
• Sanara MedTech's Change in Accured Expenses stood at $524534.0 in 2020, then retreated by 12.61% to $458405.0 in 2021, then jumped by 222.35% to $1.5 million in 2022, then climbed by 7.75% to $1.6 million in 2023, then slumped by 149.2% to -$783390.0 in 2024.
• The last three Change in Accured Expenses figures came in at -$783390.0 (Q1 2024), $1.6 million (Q4 2023), and $185400.0 (Q3 2023), per Business Quant data.